Exploration of the underlying mechanisms whereby buyang huanwu decoction improves peripheral neuropathic pain through network pharmacology and molecular docking

[Objective] To explore the mechanisms whereby Buyang Huanwu Decoction (BYHWT) imoroves peripheral neuropathic pain (PNP) through network pharmacology and molecular docking. [Methods] The active ingredients and targets of BYHWT were screened through the ETCM and SwissTargetPrediction databases. Perip...

Full description

Saved in:
Bibliographic Details
Main Authors: CHEN Kaihao, WANG Dongmei
Format: Article
Language:zho
Published: editoiral office of Journal of Diagnosis and Therapy on Dermato-venereology 2024-11-01
Series:Pifu-xingbing zhenliaoxue zazhi
Subjects:
Online Access:http://pfxbzlx.gdvdc.com/EN/10.3969/j.issn.1674-8468.2024.11.006
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850120594027184128
author CHEN Kaihao
WANG Dongmei
author_facet CHEN Kaihao
WANG Dongmei
author_sort CHEN Kaihao
collection DOAJ
description [Objective] To explore the mechanisms whereby Buyang Huanwu Decoction (BYHWT) imoroves peripheral neuropathic pain (PNP) through network pharmacology and molecular docking. [Methods] The active ingredients and targets of BYHWT were screened through the ETCM and SwissTargetPrediction databases. Peripheral neuropathic pain-related targets were screened through the GeneCards, OMIM, TTD, and DisGeNET databases. The venn diagram of intersection targets was plotted using the ggvenn package in R. The ″formulated drugs-active ingredients-disease targets″ network was constructed using Cytoscape software. The protein-protein interaction (PPI) network was established using the STRING database. Gene ontology (GO) enrichment analysis and kyoto encyclopedia of genes and genomes (KEGG) pathway enrichment analysis were performed using the clusterProfiler package in R. Molecular docking of core active ingredients and core targets was conducted using the AutoDock software. [Results] A total of 257 active ingredients and 844 affected targets were screened, along with 3 143 peripheral neuropathic pain-related targets and 478 intersection targets. The PPI analysis revealed core targets, including protein kinase Src (SRC), signal transducer and activator of transcription 3 (STAT3), protein kinase B (AKT1), and epidermal growth factor receptor (EGFR). The GO enrichment analysis identified 3 659 GO terms, encompassing 3 206 biological process, 143 cellular component and 310 molecular functions. KEGG enrichment analysis identified 303 signaling pathways, including EGFR tyrosine kinase inhibitor resistance, the AGE-RAGE signaling pathway in diabetic complications, the HIF-1 signaling pathway, and the PI3K-Akt signaling pathway. [Conclusions] Using network pharmacology and molecular docking techniques, the present study reveals that BYHWT ameliorates peripheral neuropathic pain by multiple ingredients, regulating multiple targets and signaling pathways.
format Article
id doaj-art-487581b7d31a47aa9472a97c2fec97ed
institution OA Journals
issn 1674-8468
language zho
publishDate 2024-11-01
publisher editoiral office of Journal of Diagnosis and Therapy on Dermato-venereology
record_format Article
series Pifu-xingbing zhenliaoxue zazhi
spelling doaj-art-487581b7d31a47aa9472a97c2fec97ed2025-08-20T02:35:19Zzhoeditoiral office of Journal of Diagnosis and Therapy on Dermato-venereologyPifu-xingbing zhenliaoxue zazhi1674-84682024-11-01311175776610.3969/j.issn.1674-8468.2024.11.006Exploration of the underlying mechanisms whereby buyang huanwu decoction improves peripheral neuropathic pain through network pharmacology and molecular dockingCHEN Kaihao0WANG Dongmei1School of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, ChinaSchool of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, China[Objective] To explore the mechanisms whereby Buyang Huanwu Decoction (BYHWT) imoroves peripheral neuropathic pain (PNP) through network pharmacology and molecular docking. [Methods] The active ingredients and targets of BYHWT were screened through the ETCM and SwissTargetPrediction databases. Peripheral neuropathic pain-related targets were screened through the GeneCards, OMIM, TTD, and DisGeNET databases. The venn diagram of intersection targets was plotted using the ggvenn package in R. The ″formulated drugs-active ingredients-disease targets″ network was constructed using Cytoscape software. The protein-protein interaction (PPI) network was established using the STRING database. Gene ontology (GO) enrichment analysis and kyoto encyclopedia of genes and genomes (KEGG) pathway enrichment analysis were performed using the clusterProfiler package in R. Molecular docking of core active ingredients and core targets was conducted using the AutoDock software. [Results] A total of 257 active ingredients and 844 affected targets were screened, along with 3 143 peripheral neuropathic pain-related targets and 478 intersection targets. The PPI analysis revealed core targets, including protein kinase Src (SRC), signal transducer and activator of transcription 3 (STAT3), protein kinase B (AKT1), and epidermal growth factor receptor (EGFR). The GO enrichment analysis identified 3 659 GO terms, encompassing 3 206 biological process, 143 cellular component and 310 molecular functions. KEGG enrichment analysis identified 303 signaling pathways, including EGFR tyrosine kinase inhibitor resistance, the AGE-RAGE signaling pathway in diabetic complications, the HIF-1 signaling pathway, and the PI3K-Akt signaling pathway. [Conclusions] Using network pharmacology and molecular docking techniques, the present study reveals that BYHWT ameliorates peripheral neuropathic pain by multiple ingredients, regulating multiple targets and signaling pathways.http://pfxbzlx.gdvdc.com/EN/10.3969/j.issn.1674-8468.2024.11.006peripheral neuropathic painpostherpetic neuralgiabuyang huanwu decoctionnetwork pharmacologymolecular docking
spellingShingle CHEN Kaihao
WANG Dongmei
Exploration of the underlying mechanisms whereby buyang huanwu decoction improves peripheral neuropathic pain through network pharmacology and molecular docking
Pifu-xingbing zhenliaoxue zazhi
peripheral neuropathic pain
postherpetic neuralgia
buyang huanwu decoction
network pharmacology
molecular docking
title Exploration of the underlying mechanisms whereby buyang huanwu decoction improves peripheral neuropathic pain through network pharmacology and molecular docking
title_full Exploration of the underlying mechanisms whereby buyang huanwu decoction improves peripheral neuropathic pain through network pharmacology and molecular docking
title_fullStr Exploration of the underlying mechanisms whereby buyang huanwu decoction improves peripheral neuropathic pain through network pharmacology and molecular docking
title_full_unstemmed Exploration of the underlying mechanisms whereby buyang huanwu decoction improves peripheral neuropathic pain through network pharmacology and molecular docking
title_short Exploration of the underlying mechanisms whereby buyang huanwu decoction improves peripheral neuropathic pain through network pharmacology and molecular docking
title_sort exploration of the underlying mechanisms whereby buyang huanwu decoction improves peripheral neuropathic pain through network pharmacology and molecular docking
topic peripheral neuropathic pain
postherpetic neuralgia
buyang huanwu decoction
network pharmacology
molecular docking
url http://pfxbzlx.gdvdc.com/EN/10.3969/j.issn.1674-8468.2024.11.006
work_keys_str_mv AT chenkaihao explorationoftheunderlyingmechanismswherebybuyanghuanwudecoctionimprovesperipheralneuropathicpainthroughnetworkpharmacologyandmoleculardocking
AT wangdongmei explorationoftheunderlyingmechanismswherebybuyanghuanwudecoctionimprovesperipheralneuropathicpainthroughnetworkpharmacologyandmoleculardocking